Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All protocols
B

Protocol

Replacing industrial trans fat

In controlled feeding trials, trans fatty acids raised LDL Low-density lipoprotein cholesterol, the cholesterol fraction most closely tied to plaque in the arteries. cholesterol and lowered HDL cholesterol compared with oleic acid, and a meta-analysis A study that pools the numbers from several trials into one combined estimate. of 60 trials found replacing trans fat improved the total-to-HDL cholesterol ratio about twice as much as replacing saturated fat.

Compare this record with another, side by side →

At a glance

In plain words

Trans fats are the fats made when vegetable oils are partly hardened, once common in margarine, frying fat and baked goods. In feeding trials they raised the cholesterol linked to heart disease and lowered the protective kind. No trial has counted heart attacks after taking them out of the diet.

The letter, taken apart
What was measured
LDL and HDL cholesterol on controlled diets.
How big
LDL cholesterol was 0.37 mmol/L (14 mg/dL) higher on the trans fat diet than on the oleic acid diet.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 2374566.
Who it applies to
Healthy adults on controlled diets. No trial measured heart attacks.
Safety
None specific to removing trans fat.
The record in one view
Compared with
The same diet with oleic acid (olive-oil-type fat) instead.
Certainty
Grade B, resting on: Controlled feeding trial and a meta-analysis of 60 feeding trials.
What would change this grade
Could rise to A with: Randomized trial. Who: Adults. Measured: Cardiovascular events. Length: Several years.
Cost
No price recorded yet.
Sources
2 studies cited on this record, listed under Sources.
For clinicians
A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
Food
BSurrogate biomarker Grade B

In controlled feeding trials, trans fatty acids raised LDL cholesterol and lowered HDL cholesterol compared with oleic acid, and a meta-analysis of 60 trials found replacing trans fat improved the total-to-HDL cholesterol ratio about twice as much as replacing saturated fat. No randomized trial has counted heart attacks after removing trans fat.

Why this letter

Why this gradeThe reasoning, and what the grade does not cover.
Why this grade

Grade B on LDL cholesterol. A controlled feeding trial found LDL 14 mg/dL higher and HDL 7 mg/dL lower on trans fatty acids than on oleic acid (Mensink and Katan, 1990; PMID 2374566), and a meta-analysis of 60 feeding trials confirmed that replacing trans fat improves the total-to-HDL cholesterol ratio more than replacing saturated fat (Mensink et al., 2003; PMID 12716665). LDL cholesterol is an established stand-in.

WHY NOT Ano randomized trial has counted heart attacks or deaths after removing trans fat.

WHAT THIS GRADE DOES NOT COVERnaturally occurring ruminant trans fat in dairy and meat, which these trials did not separate, and heart attacks or deaths, which no trial removing trans fat has counted.

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Who responds: this record's trial reading reports no subgroup that identifies who responds.

Evidence notes: randomized trial, meta-analysis

Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: LDL and HDL cholesterol (surrogate)

Last reviewed: November 2026

Evidence wanted

The trial that would change this grade.

DesignRandomized trial
PopulationAdults
EndpointCardiovascular events
DurationSeveral years

Positive trials of this shape from independent research groups would move this entry to A.

Why the current trials fall short

Trans fat has largely been removed from food supplies, so an outcome trial is unlikely.

Clinical trials

ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Trans Fatty Acids among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.

Search recruiting studies of Trans Fatty Acids on ClinicalTrials.gov

Dose, form and timing

What to track

Fasting LDL and HDL cholesterol.

As studiedDose, form, population and duration for every use.
As studied
FormDiet with trans fatty acids (elaidic acid) against oleic acid and saturated fat diets (Mensink 1990, PMID 2374566); controlled feeding trials of individual fatty acids (Mensink 2003, PMID 12716665).
DoseAbout 10 percent of energy from trans fatty acids (PMID 2374566); varied across the 60 pooled trials (PMID 12716665).
PopulationHealthy men and women on controlled diets (PMID 2374566); 60 controlled trials (PMID 12716665).
Duration3 weeks per diet period (PMID 2374566); weeks per trial (PMID 12716665).

A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.

Safety

Safety evidence, by strength

No safety data. Each caution on this record, sorted by what it rests on.

Documented in human studies
Cautions resting on what randomized trials or large studies found in people.

None recorded.

Suspected from case reports
Harms reported in individual patients or uncontrolled observations, not confirmed by a trial.

None recorded.

Mechanistic only
Cautions reasoned from how it works, with no human harm data behind them.

None recorded.

Population cautions
Groups in whom it has not been studied, so its safety there is unknown.

None recorded.

No safety data

No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.

Grade history

How this letter has changedLatest: No. 440 · November 2026 · First graded.
Grade history
No. 440 · November 2026 · First graded
Replacing industrial trans fat enters the food section: Grade B

New record in the food section. In controlled feeding trials, trans fatty acids raised LDL cholesterol and lowered HDL cholesterol compared with oleic acid, and a meta-analysis of 60 trials found replacing trans fat improved the total-to-HDL cholesterol ratio about twice as much as replacing saturated fat. No randomized trial has counted heart attacks after removing trans fat.PMID 2374566 PMID 12716665

Every change to a letter on this site is dated and published. The full evidence log →

Sources

How this record was checked
Citations
Every paper cited on this page is matched to its PubMed record on every build.
Retractions
None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
Read against the papers
November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
Outside review
Not yet done. No reviewer outside EBL has checked this record.

What each of these checks can and cannot show: evidence integrity.

The evidence, in fullTwo papers, each linked to its PubMed record.
The evidence

Mensink and Katan (N Engl J Med, 1990; PMID 2374566): controlled feeding trial comparing diets rich in trans fatty acids, saturated fat and oleic acid; on the trans diet LDL was 0.37 mmol/L (14 mg/dL) higher and HDL 0.17 mmol/L (7 mg/dL) lower than on the oleic acid diet. Mensink et al. (Am J Clin Nutr, 2003; PMID 12716665): meta-analysis of 60 controlled trials; replacing trans fatty acids with carbohydrates and cis unsaturated fat lowered the total-to-HDL cholesterol ratio almost twice as much as replacing saturated fat.

How EBL searched for the trials (1 search)

The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.

Searched PubMed in November 2026. 20 records screened, 2 eligible for the graded claim.
Query: ("trans fatty acid*"[tiab] OR "trans fat*"[tiab]) AND (LDL[tiab] OR cholesterol[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt])
The 20 most recent of 101 records were screened by title; newer trials test ruminant trans fat or small doses and do not change the industrial trans fat finding.
PubMed watch: does a new study change the grade? (nothing new)

No new paper matching the searches behind this grade has been added to PubMed since November 2026.

Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.

Who paid for these trials

For each trial behind a letter on this page, the funding its PubMed record lists. "No funder" means PubMed lists none, not that the trial had no funding.

  • Mensink et al., 1990, N Engl J Med (PMID 2374566): PubMed lists no funder for this trial.

Disclosure

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →

Build 9b19d78, November 2026